DF-003
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DF-003, covering 2024-05-02 to 2025-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients [Phase 1]